We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Apellis Pharmaceuticals Inc | NASDAQ:APLS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.44 | 3.13% | 47.49 | 40.00 | 48.00 | 47.74 | 46.10 | 46.62 | 1,020,629 | 23:16:48 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
SCHEDULE 13G
|
||
Under the Securities Exchange Act of 1934
|
||
(Amendment No. 3)*
|
Apellis Pharmaceuticals, Inc.
|
||
(Name of Issuer)
|
Common Stock, par value $0.0001 per share
|
||
(Title of Class of Securities)
|
037530106
|
||
(CUSIP Number)
|
December 31, 2019
|
||
(Date of Event which Requires Filing of this Statement)
|
(a)
|
Name of Issuer
|
Apellis Pharmaceuticals, Inc.
|
|
(b)
|
Address of Issuer’s Principal Executive Offices
|
Waltham, MA 02451
|
(a)
|
Name of Person Filing
|
Cormorant Global Healthcare Master Fund, LP
Cormorant Global Healthcare GP, LLC
Cormorant Private Healthcare Fund I, LP Cormorant Private Healthcare GP, LLC Cormorant Asset Management, LP Bihua Chen |
|
(b)
|
Address of Principal Business Office or, if none, Residence
|
200 Clarendon Street, 52nd Floor
Boston, MA 02116
|
|
(c)
|
Citizenship
|
Cormorant Global Healthcare Master Fund, LP - Cayman Islands
Cormorant Global Healthcare GP, LLC - Delaware
Cormorant Private Healthcare Fund I, LP - Delaware
Cormorant Private Healthcare GP, LLC - Delaware
Cormorant Asset Management, LP - Delaware
Bihua Chen - United States |
|
(d)
|
Title of Class of Securities
|
Common Stock
|
|
(e)
|
CUSIP Number
|
037530106
|
Item 3. |
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
(a)
|
[ ]
|
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
(b)
|
[ ]
|
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
|
(c)
|
[ ]
|
Insurance Company as defined in Section 3(a)(19) of the Act
|
(d)
|
[ ]
|
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
(e)
|
[ ]
|
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
(f)
|
[ ]
|
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
(g)
|
[ ]
|
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
(h)
|
[ ]
|
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
(i)
|
[ ]
|
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
(j)
|
[ ]
|
A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J);
|
(k)
|
[ ]
|
Group, in accordance with §240.13d-1(b)(1)(ii)(K).
|
Item 4. |
Ownership***
|
(a)
|
Amount Beneficially Owned***
|
|
Cormorant Global Healthcare Master Fund, LP – 1,247,685 shares
Cormorant Global Healthcare GP, LLC – 1,247,685 shares
Cormorant Private Healthcare Fund I, LP – 1,366,108 shares
Cormorant Private Healthcare GP, LLC – 1,366,108 shares Cormorant Asset Management, LP – 2,700,000 shares
Bihua Chen – 2,700,000 shares
|
||
(b)
|
Percent of Class
|
|
Cormorant Global Healthcare Master Fund, LP – 1.67%
Cormorant Global Healthcare GP, LLC – 1.67%
Cormorant Private Healthcare Fund I, LP – 1.82%
Cormorant Private Healthcare GP, LLC – 1.82% Cormorant Asset Management, LP – 3.61% Bihua Chen – 3.61% |
||
(c)
|
Number of shares as to which such person has:
|
|
(i)
|
sole power to vote or to direct the vote
|
|
Cormorant Global Healthcare Master Fund, LP - 0 shares Cormorant Global Healthcare GP, LLC - 0 shares
Cormorant Private Healthcare Fund I, LP – 0 shares
Cormorant Private Healthcare GP, LLC – 0 shares Cormorant Asset Management, LP - 0 shares
Bihua Chen - 0 shares
|
||
(ii)
|
shared power to vote or to direct the vote
|
|
Cormorant Global Healthcare Master Fund, LP – 1,247,685 shares
Cormorant Global Healthcare GP, LLC – 1,247,685 shares
Cormorant Private Healthcare Fund I, LP – 1,366,108 shares
Cormorant Private Healthcare GP, LLC – 1,366,108 shares Cormorant Asset Management, LP – 2,700,000 shares
Bihua Chen – 2,700,000 shares
|
||
(iii)
|
sole power to dispose or to direct the disposition of
|
|
Cormorant Global Healthcare Master Fund, LP – 0 shares Cormorant Global Healthcare GP, LLC – 0 shares
Cormorant Private Healthcare Fund I, LP – 0 shares
Cormorant Private Healthcare GP, LLC – 0 shares Cormorant Asset Management, LP – 0 shares
Bihua Chen – 0 shares
|
||
(iv)
|
shared power to dispose or to direct the disposition of
|
|
Cormorant Global Healthcare Master Fund, LP – 1,247,685 shares
Cormorant Global Healthcare GP, LLC – 1,247,685 shares
Cormorant Private Healthcare Fund I, LP – 1,366,108 shares
Cormorant Private Healthcare GP, LLC – 1,366,108 shares Cormorant Asset Management, LP – 2,700,000 shares
Bihua Chen – 2,700,000 shares
|
Item 8. |
Identification and Classification of Members of the Group
|
Item 9. |
Notice of Dissolution of Group
|
Item 10. |
Certification
|
Exhibits
|
Exhibit
|
99.1 | Joint Filing Agreement by and among the Reporting Persons, incorporated by reference to Exhibit 99.1 to the Schedule 13G filed by the Reporting Persons with the Securities and Exchange Commission on February 14, 2019. |
CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP
|
|
By: Cormorant Global Healthcare GP, LLC
|
|
its General Partner
|
|
By: /s/ Bihua Chen
|
|
Bihua Chen, Managing Member
|
|
CORMORANT GLOBAL HEALTHCARE GP, LLC
|
|
By: /s/ Bihua Chen
|
|
Bihua Chen, Managing Member
|
|
CORMORANT PRIVATE HEALTHCARE FUND I, LP
|
|
By: Cormorant Global Healthcare GP, LLC
|
|
its General Partner
|
|
By: /s/ Bihua Chen
|
|
Bihua Chen, Managing Member
|
|
CORMORANT PRIVATE HEALTHCARE GP, LLC
|
|
By: /s/ Bihua Chen
|
|
Bihua Chen, Managing Member
|
|
CORMORANT ASSET MANAGEMENT, LP
|
|
By: Cormorant Asset Management GP, LLC
|
|
its General Partner
|
|
By: /s/ Bihua Chen
|
|
Bihua Chen, Managing Member
|
|
/s/ Bihua Chen
|
|
Bihua Chen
|
1 Year Apellis Pharmaceuticals Chart |
1 Month Apellis Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions